Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline versus placebo after endoscopic sinus surgery for chronic rhinosinusitis
ACTRN12621000674831Phase 4Completed
- Sponsor
- Dr. Andrew James Wood
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in chronic rhinosinusitis (CRS) comparing Doxycycline with Placebo (2 arms). Primary endpoint: 22-item Sino Nasal Outcome Tool (SNOT-22) score. Started May 2023; status: completed.
02
Drugs
doxycycline
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on ACTRN12621000674831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000674831.